|
PSMG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.441600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.477800E-01 |
| Normal-vs-Stage2 |
7.345000E-01 |
| Normal-vs-Stage3 |
6.359200E-01 |
| Normal-vs-Stage4 |
5.799000E-01 |
| Stage1-vs-Stage2 |
7.146200E-01 |
| Stage1-vs-Stage3 |
5.017600E-01 |
| Stage1-vs-Stage4 |
5.636600E-01 |
| Stage2-vs-Stage3 |
4.501000E-01 |
| Stage2-vs-Stage4 |
9.325600E-01 |
| Stage3-vs-Stage4 |
2.945800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.068000E-01 |
| Normal-vs-AfricanAmerican |
7.883400E-01 |
| Normal-vs-Asian |
5.090400E-02 |
| Caucasian-vs-AfricanAmerican |
8.443400E-01 |
| Caucasian-vs-Asian |
8.420300E-02 |
| AfricanAmerican-vs-Asian |
6.072000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.236200E-01 |
| Normal-vs-Female |
5.887800E-01 |
| Male-vs-Female |
3.229000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.454600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.670400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.856200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.788800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.750200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.272600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.461600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.443700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.152600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.916600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.766600E-01 |
| Normal-vs-Grade 2 |
2.642600E-01 |
| Normal-vs-Grade 3 |
7.162000E-01 |
| Normal-vs-Grade 4 |
9.117800E-02 |
| Grade 1-vs-Grade 2 |
9.647800E-01 |
| Grade 1-vs-Grade 3 |
4.694000E-01 |
| Grade 1-vs-Grade 4 |
6.591800E-02 |
| Grade 2-vs-Grade 3 |
6.319900E-02 |
| Grade 2-vs-Grade 4 |
7.235100E-03 |
| Grade 3-vs-Grade 4 |
7.736000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.320300E-02 |
| Normal-vs-ccB subtype |
8.774300E-02 |
| ccA subtype-vs-ccB subtype |
2.40299999999527E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.904000E-01 |
| Normal-vs-N1 |
5.647000E-01 |
| N0-vs-N1 |
5.562400E-01 |
|
|
